JACQUELINE BANNISTER: Open Payments
NPI 1194089227 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,160 in 105 payments from 17 companies in 2025. Trend: 2023 $2,668 · 2024 $4,213 · 2025 $2,160
Food & beverage: $2,160
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $271 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $239 |
| Alkermes, Inc. | 7 | $230 |
| E.R. Squibb & Sons, L.L.C. | 5 | $189 |
| Axsome Therapeutics, Inc. | 9 | $171 |
| Otsuka America Pharmaceutical, Inc. | 13 | $162 |
| Vanda Pharmaceuticals Inc. | 6 | $142 |
| Janssen Pharmaceuticals, Inc | 4 | $127 |
| Neurocrine BioSciences, Inc. | 4 | $122 |
| Supernus Pharmaceuticals, Inc. | 8 | $120 |
Products named: VRAYLAR, CAPLYTA, COBENFY, Auvelity, REXULTI, INVEGA SUSTENNA, INGREZZA, Qelbree.
Industry payments across FL — which companies pay providers there.
